A procura por novos agentes com acao antimicrobiana esta se intensificando nos ultimos anos, principalmente devido ao crescente aparecimento de linhagens de micro-organismos patogenicos resistentes aos farmacos disponiveis. Substancias naturais, como o eugenol, presente nos oleos essenciais de varias plantas, e alguns compostos heterociclicos, como os derivados benzoxazolicos, sao conhecidos por apresentarem diversas propriedades biologicas, incluindo acao antimicrobiana. Buscando a obtencao de novos produtos ativos contra micro-organismos, em especial fungos, empregou-se a estrategia de hibridizacao molecular para preparar moleculas mistas contendo residuos estruturais de eugenol e de nucleo benzoxazolico. As oito substancias finais propostas foram obtidas com sucesso a partir da ciclo-oxidacao de iminas ou ciclo-condensacao de amidas, ambas derivadas de o-aminofenois originados do eugenol ou de seu analogo, diidroeugenol. O metodo baseado na ciclo-condensacao de amidas mostrou-se mais simples e eficiente. Os produtos tiveram sua identidade confirmada por meio de espectroscopia no infravermelho e de ressonancia magnetica nuclear. Esses produtos foram avaliados como antimicrobianos contra especies patogenicas ou oportunistas de Candida (C. albicans, C. krusei, C. glabrata, C. parapsilosis e C. tropicalis) e contra bacterias Gram positiva (Staphylococcus aureus) e Gram negativa (Escherichia coli). Nenhum derivado benzoxazolico apresentou atividade antibacteriana ate 100 µg.mL-¹. Por outro lado, quatro benzoxazois, 9c, 9d, 10a e 10b, apresentaram acao contra pelo menos uma especie de Candida. O produto 10a foi o mais ativo contra C. albicans e C. krusei (CI_50 = 321 µM) e o benzoxazol 10b exibiu maior potencia contra C. glabrata (CI_50 = 332 µM). As quatro substancias ativas apresentaram valores de CI_50 melhores que os descritos para o eugenol, o qual foi ativo apenas contra C. krusei (CI_50 = 610 µM). Alem desse perfil antifungico, destaca-se que esses benzoxazois foram menos citotoxicos que o eugenol frente as celulas sanguineas mononucleares humanas. Mesmo esses benzoxazois nao tendo potencia superior ao farmaco de referencia empregado no ensaio biologico (fluconazol, CI_50 = 1,6 a 104,3 µM), representam moleculas ineditas passiveis de alteracao estrutural para otimizacao de atividade. / The search for new agents with antimicrobial activity is intensifying in recent years, mainly due to the increasing appearance of pathogenic micro-organisms strains resistant to available drugs. Natural substances such as eugenol, present in the essential oils of many plants, and some heterocyclic compounds such as benzoxazoles are known for their various biological properties, including antimicrobial activity. In order to obtain new active compounds against microorganisms, especially fungi, we applied the molecular hybridization strategy to prepare mixed molecules containing structural eugenol and benzoxazole cores. The final eight substances proposed have been successfully obtained from the oxidative cyclization of imines or cyclo-condensation of amides, both derived from o-aminophenols originated from eugenol or its analogue, diidroeugenol. The benzoxazoles obtained by amide intermediates was simpler and efficient. The products had their identities confirmed by infrared spectroscopy and nuclear magnetic resonance. These products were evaluated as antimicrobial agents against pathogenic or opportunistic species of Candida (C. albicans, C. krusei, C. glabrata, C. parapsilosis and C. tropicalis) and against Gram positive bacteria (Staphylococcus aureus) and gram negative (Escherichia coli). None of the benzoxazoles showed antibacterial activity up to 100 μg.mL-1. Moreover, four benzoxazoles, 9c, 9d, 10a and 10b, presented activity against at least one species of Candida sp. The product 10a was the most active against C. albicans and C. krusei (IC_50 = 321 μM) and benzoxazole 10b exhibited higher potency against C. glabrata (IC_50 = 332 μM). These four active substances showed better IC_50 values than those for eugenol, which was only active against C. krusei (IC_50 = 610 μM). In addition to this antifungal profile, it is noteworthy that these benzoxazoles were less cytotoxic than eugenol in human blood mononuclear cells assay. Although these derivatives have not shown greater potencies than that of the reference drug used in the test (fluconazole, IC_50 = 1.6 to 104.3 μM), they represent novel chemical entities capable of structural change for activity optimization. / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq
| Identifer | oai:union.ndltd.org:IBICT/oai:10.254.254.39:tede/757 |
| Date | 20 November 2015 |
| Creators | CARVALHO, Larissa Incerti Santos de |
| Contributors | CARVALHO, Diogo Teixeira, http://lattes.cnpq.br/4247971448700418, MANFRINI, Rozângela Magalhães, DIAS, Danielle Ferreira |
| Publisher | Universidade Federal de Alfenas, Faculdade de Ciências Farmacêuticas, Brasil, UNIFAL-MG, Programa de Pós-Graduação em Ciências Farmacêuticas |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/masterThesis |
| Format | application/pdf |
| Source | reponame:Biblioteca Digital de Teses e Dissertações da UNIFAL, instname:Universidade Federal de Alfenas, instacron:UNIFAL |
| Rights | http://creativecommons.org/licenses/by-nc-nd/4.0/, info:eu-repo/semantics/openAccess |
Page generated in 0.0036 seconds